Etiology and treatment of pediatric sixth nerve palsy

J AAPOS. 2010 Dec;14(6):502-5. doi: 10.1016/j.jaapos.2010.09.009.

Abstract

Purpose: To describe the causes and treatment of sixth (abducens) nerve palsy in a series of pediatric patients.

Methods: This was a 14-year retrospective study of sixth nerve palsy in children under 14 years of age. Outcomes studied included horizontal deviation, degree of limitation of abduction, and head turn. Patients were treated with botulinum toxin injection at the time of diagnosis; surgery was indicated if treatment with botulinum toxin was unsuccessful. Success was defined as final deviation of orthotropia with no head turn or diplopia.

Results: Sixth nerve palsy was diagnosed in 15 patients (10 boys; mean age, 4.1 years) between 1995 and 2008. Involvement was bilateral in 2 cases and unilateral in 13 (7 right eyes). Causes included neoplasm (4 cases), trauma (2), idiopathic (3), congenital (2), viral (2), and inflammatory (1). Neoplastic causes were associated with other neurologic signs. Recovery was spontaneous in 5 cases (2 idiopathic, 1 traumatic, 1 congenital, and 1 inflammatory). Botulinum toxin was successful in 7 of 10 patients treated, with follow-up surgery required in the remaining 3 cases. The final result was good in all cases. In all 15 patients, mean time from diagnosis to resolution was 39 months (range, 5 to 170 months).

Conclusions: Neoplasms were the most frequent cause of sixth nerve palsy in our patient population. Recovery was spontaneous in one third of the patients. Most required treatment with botulinum toxin, which was successful in most cases. Surgery was successful after a single procedure.

MeSH terms

  • Abducens Nerve / surgery*
  • Abducens Nerve Diseases* / drug therapy
  • Abducens Nerve Diseases* / etiology
  • Abducens Nerve Diseases* / surgery
  • Acute Disease
  • Adolescent
  • Anti-Dyskinesia Agents / therapeutic use
  • Botulinum Toxins / therapeutic use*
  • Child
  • Child, Preschool
  • Chronic Disease
  • Cranial Nerve Neoplasms / complications*
  • Female
  • Humans
  • Intracranial Hypertension / complications
  • Male
  • Retrospective Studies

Substances

  • Anti-Dyskinesia Agents
  • Botulinum Toxins